CD8+ Cancer Research Results

CD8+, CD8+ T cell: Click to Expand ⟱
Source:
Type: T cell
CD8+ T cells are "end effectors" of cancer immunity.
Cytotoxic T cells expressing cell-surface CD8 are the most powerful effectors in the anticancer immune response and form the backbone of current successful cancer immunotherapies.
CD8+ T cells, also known as cytotoxic T lymphocytes (CTLs), play a crucial role in the immune response against cancer. They are responsible for identifying and killing cancer cells that present abnormal antigens, which can arise from mutations or viral infections.


HCC, Hepatocellular Carcinoma: Click to Expand ⟱
Hepatocellular Carcinoma

Scientific Papers found: Click to Expand⟱
5892- CAR,  SRF,    Carvacrol potentiates immunity and sorafenib anti-cancer efficacy by targeting HIF-1α/STAT3/ FGL1 pathway: in silico and in vivo study
- in-vivo, HCC, NA
Hif1a↓, AFP↑, hepatoP↑, STAT3↓, JAK2↓, *CD8+↑, ChemoSen↑, Dose↝, angioG↓,
1033- CHr,    Chrysin inhibits hepatocellular carcinoma progression through suppressing programmed death ligand 1 expression
- vitro+vivo, HCC, NA
TumCG↓, CD4+↑, CD8+↑, PD-L1↓,

Showing Research Papers: 1 to 2 of 2

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 2

Pathway results for Effect on Cancer / Diseased Cells:


Proliferation, Differentiation & Cell State

STAT3↓, 1,   TumCG↓, 1,  

Angiogenesis & Vasculature

angioG↓, 1,   Hif1a↓, 1,  

Immune & Inflammatory Signaling

CD4+↑, 1,   JAK2↓, 1,   PD-L1↓, 1,  

Drug Metabolism & Resistance

ChemoSen↑, 1,   Dose↝, 1,  

Clinical Biomarkers

AFP↑, 1,   PD-L1↓, 1,  

Functional Outcomes

hepatoP↑, 1,  

Infection & Microbiome

CD8+↑, 1,  
Total Targets: 13

Pathway results for Effect on Normal Cells:


Infection & Microbiome

CD8+↑, 1,  
Total Targets: 1

Scientific Paper Hit Count for: CD8+, CD8+ T cell
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:10  Cells:%  prod#:%  Target#:344  State#:%  Dir#:2
wNotes=0 sortOrder:rid,rpid

 

Home Page